Nephros (NEPH) Shares Outstanding (2010 - 2026)

Nephros has reported Shares Outstanding for 17 years, with the latest figure at $10.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 2.29% year-over-year to $10.8 million; the trailing twelve-month figure through Mar 2026 stood at $10.8 million (up 2.29% YoY), and the FY2025 full-year result was $10.6 million, up 0.94% from the prior year.
• Shares Outstanding for Q1 2026 stood at $10.8 million, up from $10.6 million in the prior quarter.
• The five-year high for Shares Outstanding was $10.8 million in Q1 2026, with the low at $10.3 million in Q1 2022.
• Average Shares Outstanding over 5 years is $10.5 million, with a median of $10.5 million recorded in 2024.
• Year-over-year, Shares Outstanding grew 3.75% in 2022 and dropped 0.06% in 2023.
• Tracing NEPH's Shares Outstanding over 5 years: stood at $10.3 million in 2022, then advanced by 1.98% to $10.5 million in 2023, then gained by 0.41% to $10.5 million in 2024, then climbed by 0.94% to $10.6 million in 2025, then gained by 1.87% to $10.8 million in 2026.
• The last three Shares Outstanding figures came in at $10.8 million (Q1 2026), $10.6 million (Q4 2025), and $10.6 million (Q3 2025), per Business Quant data.

Peer Comparison